Cromos Pharma

Cromos Pharma Cromos Pharma is an international research organization (CRO) specializing in clinical trials. Find out more by visiting www.cromospharma.com.

Established in 2004, Cromos Pharma provides tailored and effective clinical trial services to support the development of drugs that transform healthcare. It is an international CRO with over 15 years' experience in offering fully integrated services and delivering all aspects of clinical trials in all clinical phases and a range of therapeutic areas. Cromos Pharma delivers rapid recruitment and excellent patient retention as well as expert study design and management. Cromos Pharma has strong regional experience in Central and Eastern Europe. Its US base is in Portland, Oregon with additional operations in South Florida and its European HQ is situated in Dublin, Ireland.

In the latest edition of Cromos Pharma’s Newsletter, we highlight key stories shaping the start of 2026:– Cromos Pharma ...
01/07/2026

In the latest edition of Cromos Pharma’s Newsletter, we highlight key stories shaping the start of 2026:

– Cromos Pharma Video Release: 12 Stories of Courage and Cure reflects defining moments in medical research, celebrating the courage of patients, researchers, and physicians whose work continues to move science forward.
– Rare Disease Milestone: The FDA approves the first gene therapy for Wiskott–Aldrich syndrome, opening a new treatment pathway for a life-threatening genetic condition.
– Autoimmune Breakthrough: Kyverna’s CAR-T therapy delivers registrational success in stiff person syndrome, setting the stage for the first FDA filing of a CAR-T treatment in autoimmune disease.

Read the full January Newsletter: https://cromospharma.com/clinical-research-focus-48th-edition/

01/05/2026

We’re pleased to announce that Vlad Bogin, MD, FACP, CEO of Cromos Pharma, will be attending the 44th Annual J.P. Morgan Healthcare Conference, held January 12–15, 2026, in San Francisco, CA.

Widely regarded as the premier global healthcare investment event, JPM 2026 convenes leaders from biopharma, medtech, and the investment community to exchange insights on emerging trends, strategic priorities, and partnership opportunities for the year ahead.

During the conference, Dr. Bogin welcomes the opportunity to engage with industry peers, discuss perspectives on clinical development and investment strategy, and explore potential areas for collaboration.

To arrange a meeting with Dr. Bogin at JPM 2026, please reach out to us at inquiry@cromospharma.com.

12/29/2025

Happy New Year 2026!

From all of us at Cromos Pharma, we wish you a year filled with health, happiness, and new opportunities.

May 2026 bring clarity, progress, and meaningful success — both professionally and personally. Here’s to a bright year ahead!

As 2025 comes to a close, FDA approvals offer more than scientific milestones — they reveal how clinical trials are evol...
12/22/2025

As 2025 comes to a close, FDA approvals offer more than scientific milestones — they reveal how clinical trials are evolving.

This year highlighted a clear shift toward ultra-precise patient populations, biomarker-driven development, and accelerated regulatory pathways. From oncology and hematology to RNA therapeutics and infectious disease prevention, these approvals point to where clinical trial strategy is headed next.

Read the full analysis: https://cromospharma.com/the-most-transformative-fda-approvals-of-2025-therapies-redefining-clinical-research-and-future-trial-strategy/

As the year draws to a close, we find ourselves reflecting on what truly moves medical science forward. Beyond data, pro...
12/18/2025

As the year draws to a close, we find ourselves reflecting on what truly moves medical science forward. Beyond data, protocols, and milestones, it is courage — the courage of patients, physicians, researchers, and teams who continue forward even in moments of uncertainty — that ultimately drives progress.

This Christmas season, we are pleased to share “12 Stories of Courage and Cure,” a short video highlighting meaningful moments in medical research where perseverance, innovation, and compassion came together to change lives.

🎬 Watch here: 12 Stories of Courage and Cure
https://cromospharma.com/12-stories-of-courage-and-cure-a-holiday-message-from-cromos-pharma/

We hope these stories offer a moment of reflection, renewed purpose, and optimism as we look ahead to the year to come.

On behalf of the entire Cromos Pharma team, we wish you a warm and joyful Christmas, peaceful holidays spent with those who matter most, and a healthy, hopeful start to 2026.

12/17/2025

Cromos Pharma is currently seeking an In-House CRA to join our team.
Location: Hungary

For additional details about this exciting opportunity, please visit our website: https://cromospharma.com/in-house-cra/

If you're ready to take the next step in your career with Cromos Pharma, kindly send your CV to cv@cromospharma.com

12/15/2025

We are delighted to share that Vlad Bogin, MD, FACP, CEO of Cromos Pharma, will be attending the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12–15, 2026, in San Francisco, CA.

Recognized as the world’s most influential healthcare investment conference, JPM 2026 brings together global biopharma and medtech leaders, innovators, and the investment community to discuss the trends, partnerships, and strategies shaping the year ahead.

Dr. Bogin looks forward to connecting with peers, exchanging perspectives on clinical development and investment strategy, and exploring new opportunities for collaboration.

If you would like to schedule a meeting with Dr. Bogin during the event, please contact us at inquiry@cromospharma.com.

12/12/2025

As Hanukkah approaches, we extend warm wishes to our clients, partners, colleagues, and friends who celebrate this meaningful holiday. May these eight days be filled with light, joy, and moments shared with those who matter most.

Wishing you a happy and blessed Hanukkah.

In the latest edition of Cromos Pharma’s Newsletter, we spotlight key breakthroughs shaping clinical research:– Alzheime...
12/12/2025

In the latest edition of Cromos Pharma’s Newsletter, we spotlight key breakthroughs shaping clinical research:

– Alzheimer’s Care Advances: Blood tests, AI tools, and next-gen therapies enable earlier, more personalized intervention.
– FDA Tightens Elevidys Use: Boxed warning issued after fatal liver complications in non-ambulatory DMD patients.
– mRNA Cancer Vaccines Accelerate: Emerging data show strong signals across multiple tumors, advancing precision immunotherapy.

Read the full December Newsletter here: https://cromospharma.com/clinical-research-focus-47th-edition/

12/02/2025

Cromos Pharma is currently seeking a Project Manager to join our team.

Location: Europe

For additional details about this exciting opportunity, please visit our website: https://cromospharma.com/project-manager/

If you're ready to take the next step in your career with Cromos Pharma, kindly send your CV to cv@cromospharma.com

11/26/2025

Happy Thanksgiving!

On this day of gratitude, Cromos Pharma extends warm appreciation to our dedicated team, trusted partners, valued clients, and dear friends.

May your Thanksgiving be filled with light, joy, and meaningful moments as we honor the relationships and shared achievements that inspire our work every day!

Address

US Bancorp Tower, 111 S. W. Fifth Avenue, Suite 3150
Portland, OR
97204

Telephone

+15034443463

Website

Alerts

Be the first to know and let us send you an email when Cromos Pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram